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Analytical Method Development and Validation: Requirements
in Pharmaceutical Field
Hetal Bhenjaliya, Rohan Barse*
Email: barserohan@gmail.com

Abstract
Analytical method validation needed during the production and manufacture of drugs and such analytical
procedure is sufficient for their intended purpose. The development of methods usually requires the collection
of method specifications and the decision on the type of instrumentation. This needs a system of analyzing
herbal products, new processes, and reactions, new compounds, active ingredients (macro analysis), residues
(microanalysis), impurity profiling, etc.
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Introduction
The creation of methods usually requires the
collection of method specifications and the types of
instrumentation to be determined1. It includes an
analytical approach for herbal products, new processes
and reactions, new ingredients, active substances
(macro analysis), residues (microanalysis), impurity
profiling, etc. This review article discusses the steps
involved in developing and validating a drug molecule
analytical approach in the pharmaceutical field2,3.
Analytical measurements are linked to every aspect
of society and there are countless explanations as to
why these measurements are made. It is obviously
important to determine the correct outcome and to
be able to demonstrate that it is accurate.
Some of the prominent
organizations are5:
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1. World Health Organization (WHO)
2. Pharmaceutical Inspection Cooperation Scheme
(PIC/S)
3. United States Food and Drug Administration
(US FDA)
4. The International Conference for Harmonization
(ICH)
5. Current Good Manufacturing Practice (cGMP)
regulations
6. Good Laboratory Practice (GLP) regulations.
7. Pharmaceutical Inspection Cooperation Scheme
(PIC/S)
Reasons valid for developing new analytical
process
1. Costly reagents and solvents required
current analytical procedures. It also requires
burdensome extraction procedures and
separation.
2. Existing methods may be unreliable.
3. A similar sample matrix may not contain a
suitable method for a specific analyte.
4. Existing technologies could be too complicated,
cumbersome, not easily automated.
5. Current techniques may not have been
appropriately resilient.
6. Cannot consider analytical methods for
quantifying the analyte in biological fluids
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Goals for a new or better theoretical process
1. Direct transmission of qualitative or
quantitative data to laboratory computers for
assessment, analysis, printing, and transmission
via a network to other locations.
2. Sample preparation reducing the time, energy,
materials and sample volume consumed by using
simple quality assurance and quality control
procedures reduced costs per analysis.
3. Qualitative description of special interest
analytes, with some structural details.
4. Upon installation of the instrumentation
and consideration of analyte parameters, the
specifications should be used to further build,
refine and test the system.
Steps in the analytical method development6
1. Analyte standard characterization
• While analyzing multiple components in the
sample matrix, the number of components
that pose the data is noted, and normal
usability is calculated.
• Sample stability methods such as spectroscopic,
high performance liquid chromatography
(HPLC), gas chromatography (GC), mass
spectrometry (MS), etc.
• Consider the availability of standards for
degradation products, possible impurities
and synthetic precursors. The purity of all
standards to be used in method development
should be established and documented.
2. Method requirements
• Find the aims or parameters of the analytical
methods to be set and describe the figures of
the analytical merit.
• Additional criteria (time, energy, effort, time
of analysis, available tools) tool limitations
(pressure and solvents) and cost per analysis
3. Literature search and prior methodology
• Consider the objectives of the analytical
methods to be established and all literature
information relating to the drug is checked
for relevant books, articles, United State
Pharmacopoeia/
National
Formulary
(USP/NF), Association of
analytical
communitiesand American society for testing

and materials publications for physicochemical
properties, synthesis, solubility, and correct
analytical methods.
• To decide if any analytical work on the
analyte has ever been carried out within the
company, and if so, to collect data, findings,
records, memos, and publications.
4. Choosing a method
• If no methods are available to investigate the
analyte to be analyzed in the past.
• Adopt sample preparation and instrument
conditions (e.g. HPLC) wherever possible
to take advantage of the latest methods and
technologies.
5. Instrument setup and initial studies
• Installation, function and performance
evaluation of the instrumentation in respect
of laboratory standard operating procedures
shall be verified by defining the appropriate
instrumentation
• Starting with an accurate, proven norm is
essential, rather than a complex matrix of
samples.
6. Optimization
• If initial analytical results are less than
optimal, start the optimization cycle, keeping
the method’s goal in mind. If necessary, using
computer-based optimization tools.
• Pay special attention to experimental design
during optimization.
7. Demonstration of investigative data of value
with standards
• First, give customized empirical merit
figures for the rule, before dealing with the
actual research. The norm can not meet the
required figures of empirical validity, and the
study of the sample is futile.
• If the analytical merit figures are standardized
and recorded, including standardization of
items such as integration parameters and any
statistical data treatment (when necessary),
then sample analysis can start.
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8. Evaluation of proven methods with actual
samples: Derivation of figures of merit
• Working with actual samples, conduct sample
preparation steps to ensure analyte peak
detection capability apart from any other
possible interferences and contaminants.
• Ideally, a “dilute and shoot” sample
preparation will minimize the time and cost
of the overall analysis. At the same time,
one must remember to provide an injection
solution that is compatible with the HPLC/
MS system.
9. Validation of figures of merit
• Validate the method once it has been developed
and optimized. Regulatory laboratories (FDA)
perform method validation by evaluating and
documenting the USP.
• The eight parameters of method validation
namely accuracy, linearity, range, limit of
detection (LOD), limit of quantification
(LOQ), specificity, ruggedness and sturdiness.
10. Determination of percentage of sample
recovery and quantitative sample analysis
• An average percentage of the recovery in a
sample matrix of spiked, genuine standard
drug that contains no analyte. Recovery
optimization has to be shown from sample
to sample for reproducibility (average ±
standard deviation)
11. Method validation
• Perform zero blind studies to demonstrate that
known levels can be accurately and precisely
determined in a real sample.
• Perform double-blind studies to further
demonstrate the quantitative accuracy and
precision of the overall method.
• Demonstrate repeatability of analytical results,
within a single laboratory.
• Demonstrate analytical figures of merit
reproducibility (ruggedness), from lab to lab,
analyst to analyst, instrument to instrument,
and so on, as required.
• Carry out additional analysis using the analyte’s
credible sample matrix selected reaction
monitoring (SRM)of major interest. If there
62
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is no SRM available, have one synthesized
outside, contract laboratory that will guarantee
composition authenticity and identity.
12. Preparation of written protocols and
procedures
• Ensure that all necessary and sufficient
details of the method are stated so that other
labs can reproduce, as closely as possible, the
experimental conditions.
• Provide specific suppliers, addresses, catalog
numbers, batch numbers, purity levels, and
any other unique identifying features that
will ensure that other analysts obtain the
exact items to duplicate the method.
13. Transfer of method technology to outside
laboratories: Interlaboratory collaborative
studies
• Continue method validation (ruggedness)
outside the original laboratory by performing
interlaboratory
collaborative
studies.
interlaboratory studies can be accomplished
by splitting known, authenticated samples
and dispensing them to other laboratories
while providing them with a complete
procedure of the overall, final method.
14. Comparison of interlaboratory studies
• Summarize and statistically compare
validation results from interlaboratory
collaborative studies to demonstrate whether
the method can be transferred to other
facilities and provide similar accuracy and
precision of the quantitative results.
15. Preparation of summary report on overall
method validation results
• Prepare a summary report that includes
results from all laboratories where the
method was employed, with qualitative and
quantitative results statistically treated.
16. Summary report of final method procedures
and results, and preparation of journal article
for submission.
Sampling collection for the development of an
analytical tool
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Make the quantification of impurities accurate at
low levels which is essential in defining the quality
of pharmaceutical products. To that end, a great
deal of time is devoted to developing methods to
meet these needs. The first step of this development
project must be to define and gather a set of samples
containing any potential and actual impurities
that need to be assessed by the purity method.
With this set in hand, subsequent development
experiments can assure that a method or methods
can accurately and completely determine the purity
of a pharmaceutical product.
This paper provides detailed guidance in selecting
the set of samples that contain the compounds
of interest that must be quantified at low levels
for a pharmaceutical product. A list of potential
components and their sources is provided. Guidance
is given on sample-screening techniques and
when to eliminate samples that are redundant or
unnecessary. Finally, techniques are outlined to
enrich and combine samples in order to minimize
the sample set.
Method Development in Chromatography 7
Problems in method development
1. Stored samples are initially accurate but slowly
become inaccurate with low bias
2. Absorption issue: A serially diluted curve
is concave. The response factors drop with
decreasing concentration. An increased
exposure due to the number of dilutions, surface
area contact, and time may cause this problem
3. Homogeneity: The sample to be analyzed gets
partitioned.
The detector must then be selected to provide the
required sensitivity, the necessary. These are some
of the basic options, but there are many others to
make, such as an internal or external standard, the
sampling process, the need for gradient elution or
temperature programming, sensitivity to detectors,
etc. The efficient implementation of the system
includes expertise in chromatographic science and
comprehensive practical experience.
Spectrophotometric methods
These approaches are reliable and consistent
with good reproducibility but due to costly

instrumentation, reagent, and expertise the cost of
the study is quite high. Such methods are reliable
and consistent with good reproducibility, but the
pharmaceutical analyst also takes into consideration
a situation where concentration of one or more
substances is required in samples known to contain
other absorbent substances that may interfere with
the assay.
If the sampling method is known, the interfering
material’s identity and concentration is known, and
the degree of interference may be measured in the
study. The analyst has a number of modifications to
the basic spectrophotometric technique which can
eliminate some sources of interference and allow all
absorbing components to be measured accurately.
Some changes to the basic procedure can be made
if certain criteria are met. The basis of all the
spectrophotometric techniques for multicomponent
samples is the possessions that at all wavelengths:
•

•

The sum of absorption of the individual
components is the absorption of a solution.
or
Precise absorption is the difference between the
overall absorption of the sample cell solution
and that of the reference cell solution.

There are various spectrophotometric methods
available that can be used to test a mixture sample.
They can be used according to methods:
• Difference spectrophotometry
• Derivative spectrophotometric method
• Method for absorbing the ratio (Q-Absorbance
method)
• Simultaneous equation method
Assay bias and factor for the response of analytes
All analytical procedures are associated with a
number of biases, particularly biological assays,
that test for biopharmaceutical purity, potency, and
molecular interactions. Adequate reference criteria
may also not be readily available, as the commodity
may be one of a kind. The most difficult part of the
production and testing process can be determining
the accuracy and bias of the assay. Comparing the
findings of the new method with those of the old
method often only makes sense when controlling for
bias in the test.
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Stability
The detection limit for a single analytical technique
is the lowest analyte quantity in a sample that can be
detected. The standard deviation of the response and
the slope can be measured visually, by signal to noise
ratio. Only analytical procedures that show baseline
noise can be added to the detection limit signal to
the noise method. Comparison of measured signals
from samples with identified analyte concentrations
with those from blank samples and the minimum
level at which the analyte can be detected reliably. A
signal-to-noise ratio of 3 or 2:1 is generally deemed
appropriate for the detection limit estimate. The
Detection Limit (DL) can be represented as DL=3.3
π/S where, while the answer is standard deviation,
the calibration curve slope is S. The slope S can be
estimated from the analyte’s calibration curve. It can
be measured in a variety of ways, depending on the
standard deviation of the blank and the calibration
curve.
The USP eight steps of method validation8
• Detection limit
• Quantitation limit
• precision
• linearity & size
• robustness
• Accuracy
Validation parameters for ICH method8,9
• Accuracy
• Detection limit
• Quantitation limit
• Specificity
• Linearity
• Distance
• Robustness
• Adaptability to the device
The assay validation carried out as per the parameters
mentioned below10,11,12 .
The process type and its intended use determines
the parameter to be investigated. The USP divide
analytical method into:
1. Determination of performance characteristics.
2. Main components or active ingredients
quantified
64
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3. The determination of impurities or products for
degradation
Table 1: Various analytical parameters and assay categories
Analytical
performance
parameter

Assay
category
1

Assay
category
2
Q L

Assay
category 3

Accuracy

Y

Y

*

Precision

Y

Y

N

Y

Specificity

Y

Y

Y

*

LOD

N

N

Y

*

LOQ

N

Y

N

*

Linearity

Y

Y

N

*

Range

Y

Y

*

*

Ruggedness

Y

Y

Y

Y

(Y=YES, N=NO)
Q = quantitative
L= limit test
*= Can be required according to the nature of the particular
test

Accuracy
It is the calculation of an empirical method’s
precision, or the consistency of agreement between
the calculated value and the true or agreed reference
value.
Precision
It is the estimate of the degree of repeatability in
the normal operation of a methodical process.
Specificity
In the being thereof other components that may
be assumed to be present in the sample matrix, it
is the ability to calculate accuracy and precisely the
analysis value.
LOD
It is identified in a sample as the lowest analyte
concentration that can be detected, but not
necessarily quantitated.
LOQ
It is defined as the lowest concentration of
analytes in a sample that can also be measured
with appropriate precision and accuracy under the
operating conditions specified by the method.
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Linearity and range
Linearity is the system’s ability to produce test
results within a given range which are directly
proportional to the concentration of the analyte.
Range
Using the method the interval between the upper
and lower analyte levels was shown to be accurate,
accurate and linear.
Ruggedness
It is the degree of reproducibility of experiments,
expressed as a percentage Relative Standard
Deviation (RSD), which has been obtained under
various conditions.
Robustness
The method’s robustness is assessed using various
method parameters such as organic solvent
percentage, temperature, organic strength, and the
effect on the method’s performance.
Conclusion:
The analytical method development is the need of
pharmaceutical industries. It usually needs the set of
requirements for the system and the decision on the
instrumentation type. It includes a system of study
of herbal products, new processes and reactions,
new chemicals, active ingredients (macro analysis),
residues (microanalysis), profiling of impurities, and
so on.
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